These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1600132

  • 1. Immunopathological aspects of immunoglobulin A nephropathy and other mesangial proliferative glomerulonephritides.
    Schena FP, Gesualdo L, Montinaro V.
    J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S167-72. PubMed ID: 1600132
    [Abstract] [Full Text] [Related]

  • 2. Expression of cytokines and growth factors in human glomerulonephritides.
    Waldherr R, Noronha IL, Niemir Z, Krüger C, Stein H, Stumm G.
    Pediatr Nephrol; 1993 Aug; 7(4):471-8. PubMed ID: 8398664
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic characterization of cytokine expression in patients with IgA nephropathy.
    Yano N, Endoh M, Nomoto Y, Sakai H, Fadden K, Rifai A.
    J Clin Immunol; 1997 Sep; 17(5):396-403. PubMed ID: 9327339
    [Abstract] [Full Text] [Related]

  • 4. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 5. Future directions in the treatment of IgA nephropathy.
    Lai KN.
    Nephron; 2002 Oct 05; 92(2):263-70. PubMed ID: 12218302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential effects of circulating IgA isolated from patients with IgA nephropathy on superoxide and fibronectin production of mesangial cells.
    Chen HC, Guh JY, Chang JM, Lai YH.
    Nephron; 2001 Jul 05; 88(3):211-7. PubMed ID: 11423751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Altered synthesis of interferon-gamma and expression of interferon-gamma receptor by peripheral blood mononuclear cells from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis.
    Yano N, Endoh M, Naka R, Takemura F, Nomoto Y, Sakai H.
    J Clin Immunol; 1996 Jan 05; 16(1):71-9. PubMed ID: 8926288
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.
    Horii Y, Iwano M, Hirata E, Shiiki M, Fujii Y, Dohi K, Ishikawa H.
    Kidney Int Suppl; 1993 Jan 05; 39():S71-5. PubMed ID: 8468929
    [Abstract] [Full Text] [Related]

  • 12. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
    Liang Y, Zhao G, Tang L, Zhang J, Li T, Liu Z.
    Exp Cell Res; 2016 Oct 01; 347(2):312-21. PubMed ID: 27542871
    [Abstract] [Full Text] [Related]

  • 13. Increase of CD23-positive cells in peripheral blood from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis.
    Yano N, Miyazaki M, Endoh M, Kuramoto T, Eguchi K, Yagame M, Nomoto Y, Sakai H.
    Nephron; 1992 Oct 01; 60(4):404-10. PubMed ID: 1533901
    [Abstract] [Full Text] [Related]

  • 14. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
    Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2002 Oct 01; 53(3):155-62. PubMed ID: 12476618
    [Abstract] [Full Text] [Related]

  • 15. Extrarenal cytokines modulate the glomerular response to IgA immune complexes.
    Montinaro V, Hevey K, Aventaggiato L, Fadden K, Esparza A, Chen A, Finbloom DS, Rifai A.
    Kidney Int; 1992 Aug 01; 42(2):341-53. PubMed ID: 1405317
    [Abstract] [Full Text] [Related]

  • 16. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
    Danilewicz M, Wagrowska-Danilewicz M.
    J Nephrol; 1998 Aug 01; 11(5):255-60. PubMed ID: 9831239
    [Abstract] [Full Text] [Related]

  • 17. Proliferative glomerulonephritis with monoclonal immunoglobulin A light-chain deposits in the renal allograft.
    Setoguchi K, Kawashima Y, Tokumoto T, Toma H, Mizoguchi S, Horita S, Yamaguchi Y, Tanabe K.
    Nephrology (Carlton); 2014 Jun 01; 19 Suppl 3():49-51. PubMed ID: 24842824
    [Abstract] [Full Text] [Related]

  • 18. Case report on mesangial proliferative glomerulonephritis with multicentric Castleman's disease: Approach to the onset mechanism of immunoglobulin A nephropathy.
    Karasawa K, Ogura S, Miyabe Y, Akiyama K, Nitta K, Moriyama T.
    Clin Immunol; 2020 Mar 01; 212():108347. PubMed ID: 31978558
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY, Ku FM, Kuo YC, Chen CF, Chen WP, Chen A, Shiao MS.
    J Lab Clin Med; 1999 Jan 01; 133(1):55-63. PubMed ID: 10385482
    [Abstract] [Full Text] [Related]

  • 20. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.
    Lin TJ, Yang SS, Hua KF, Tsai YL, Lin SH, Ka SM.
    Free Radic Biol Med; 2016 Oct 01; 99():214-224. PubMed ID: 27519267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.